Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
40 participants
OBSERVATIONAL
2018-09-01
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia
NCT01459029
Safety and Effectiveness of D-serine in Schizophrenia
NCT00322023
D-serine Monotherapy for Schizophrenia
NCT00816894
Israel Multicenter D-Serine Study (IMSER) for the Treatment of Schizophrenia
NCT00138775
D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia
NCT00237809
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
starch
D-serine
dosage
High Dose
3.5 g/d D-serine adjuvant treatment
D-serine
dosage
Low Dose
2.1 g/d D-serine adjuvant treatment
D-serine
dosage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
D-serine
dosage
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herzog Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heresco-Levi Uriel
Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Uriel Heresco-Levy, MD
Role: PRINCIPAL_INVESTIGATOR
Herzog Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herzog Hospital
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HerzogHospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.